Neuromuscular Monitoring
摘要
Neuromuscular monitor devices were introduced into clinical practice in the 1970s. In 1979, Viby Mogensen et al. reported that 42% of patients administered a long acting neuromuscular blocking agent (NMBA) in the operating room arrived in the post anaesthesia care unit with objective evidence of postoperative residual neuromuscular block (defined as that time as train of four ratio [TOF] ratio < 0.7).